542 results on '"Chu, Justin Jang Hann"'
Search Results
2. Alterations in colorectal cancer virome and its persistence after surgery
3. Attenuation of neurovirulence of chikungunya virus by a single amino acid mutation in viral E2 envelope protein
4. Tanomastat exerts multi-targeted inhibitory effects on viral capsid dissociation and RNA replication in human enteroviruses
5. Construction of Infectious Clones for Human Enteroviruses
6. Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
7. Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti
8. Retraction Note: Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection
9. The 8-bromobaicalein inhibited the replication of dengue, and Zika viruses and targeted the dengue polymerase
10. Author Correction: The 8-bromobaicalein inhibited the replication of dengue, and Zika viruses and targeted the dengue polymerase
11. Expanding the anti-flaviviral arsenal: Discovery of a baicalein-derived Compound with potent activity against DENV and ZIKV.
12. Chelerythrine chloride inhibits Zika virus infection by targeting the viral NS4B protein
13. AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice
14. SARS-CoV-2 Omicron variant shedding during respiratory activities
15. Diagnostic performance of different specimens in detecting enterovirus A71 in children with hand, foot and mouth disease
16. CUR-N399, a PI4KB inhibitor, for the treatment of Enterovirus A71 infection
17. Microbial resistance to nanotechnologies: An important but understudied consideration using antimicrobial nanotechnologies in orthopaedic implants
18. Discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection
19. Platelets in the pathogenesis of flavivirus disease
20. Author Correction: Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection
21. Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
22. Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection
23. Cytopathic Effect (CPE)-Based Drug Screening Assay for SARS-CoV-2
24. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility
25. Carry forward advantages of traditional medicines in prevention and control of outbreak of COVID-19 pandemic
26. DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response
27. Oligopolyphenylenevinylene-Conjugated Oligoelectrolyte Membrane Insertion Molecules Selectively Disrupt Cell Envelopes of Gram-Positive Bacteria
28. Characterization of oral virome and microbiome revealed distinctive microbiome disruptions in paediatric patients with hand, foot and mouth disease
29. A single-dose live attenuated chimeric vaccine candidate against Zika virus
30. Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition
31. The molecular epidemiology of a dengue virus outbreak in Taiwan: population wide versus infrapopulation mutation analysis.
32. Potential relevance of salivary legumain for the clinical diagnostic of hand, foot, and mouth disease
33. Flavivirus genome recoding by codon optimisation confers genetically stable in vivo attenuation in both mice and mosquitoes
34. Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy
35. Drug repurposing of quinine as antiviral against dengue virus infection
36. Enterovirus-A71 exploits peripherin and Rac1 to invade the central nervous system
37. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies
38. Pandemic Preparedness: The Singapore Drug Repurposing Antiviral Strategy
39. Enterovirus-A71 exploits Rab11 to recruit chaperones for virus morphogenesis
40. Recent advances in therapeutic recruitment of mammalian RNAi and bacterial CRISPR-Cas DNA interference pathways as emerging antiviral strategies
41. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications
42. Antiviral Activity of Catechin against Dengue Virus Infection
43. SETDB1 acts as a topological accessory to Cohesin via an H3K9me3-independent, genomic shunt for regulating cell fates
44. Pomegranate activates TFEB to promote autophagy-lysosomal fitness and mitophagy
45. Recent advances on the role of host factors during non-poliovirus enteroviral infections
46. In utero infection of Zika virus leads to abnormal central nervous system development in mice
47. The identification and phylogenetic analysis of SARS‐CoV ‐2 delta variants in Taiwan
48. Evaluation of In Vitro and In Vivo Antiviral Activities of Vitamin D for SARS-CoV-2 and Variants
49. Lichen-Derived Diffractaic Acid Inhibited Dengue Virus Replication in a Cell-Based System
50. Detection of hospital environmental contamination during SARS-CoV-2 Omicron predominance using a highly sensitive air sampling device
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.